PLE-3585
A recent study by Albert et al. in the NEJM made the case for the use of Azithromycin in the prevention of exacerbations of COPD. This is because Azithromycin is active against the most common bacterial cause of COPD, which is:
A recent study by Albert et al. in the NEJM made the case for the use of Azithromycin in the prevention of exacerbations of COPD. This is because Azithromycin is active against the most common bacterial cause of COPD, which is: